CAMK2G and myeloid sarcoma: It has previously been shown that numerous experimentally validated CaMBPs are involved in multiple neuroinflammatory events including Aβ (AD, PD, MS), BACE1 (AD, PD), BIN1 (AD, LBD), CaMKII (AD, PD, HD.